OGN vs REGN Stock Comparison
REGN currently leads OGN in this stock comparison, with AIQ scores of 68 vs 64. The clearest difference is quality, while OGN has the stronger value profile.
What is the main difference between OGN and REGN?
REGN leads the current stock comparison as Regeneron Pharmaceuticals, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Organon & Co. vs Regeneron Pharmaceuticals, Inc.
REGN leads
REGN leads by 4 AIQ points, primarily on Quality and Momentum, having only recently taken the lead back from OGN.
Fragile: 2 of 6 evidence groups support REGN, the lead recently changed hands, and its signal state is cleanly positive.
Organon & Co.
Regeneron Pharmaceuticals, Inc.
The Algovestiq AIQ Score currently favors REGN over OGN, 68 versus 64 as of Oct 21, 2026. REGN's advantage is driven primarily by stronger quality and momentum, while OGN holds the stronger value profile. REGN also shows the stronger technical structure relative to its 50-day moving average. 2 of 6 covered evidence groups favor REGN today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 4 points. REGN lead: Reversed — OGN led by 17 AIQ points 30 sessions ago; REGN now leads by 4.
Compare Organon & Co. and Regeneron Pharmaceuticals, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare OGN and REGN against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Value75 vs 48OGN +27
- Quality47 vs 73REGN +26
- Momentum69 vs 91REGN +22
- Risk Resilience70 vs 60OGN +10
2 of 6 evidence groups favor REGN. REGN’s edge is concentrated in quality and momentum; OGN keeps a meaningful value edge.
What changed since the last close
Latest scored session 2026-10-20, compared against the prior scored session 2026-10-19.
Largest factor move: Momentum +6
No signal started or stopped since the prior session; its 6 active signals are unchanged.
Largest factor move: Momentum +17
New signals
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Uptrend Structure Active — bullish, trend, long horizon
REGN's lead widened by 3 AIQ points in the latest session.
Deeper signal detail for each name lives on its own signals page — OGN and REGN both carry a full feed there.
The central trade-off
REGN (Regeneron Pharmaceuticals, Inc.): the stronger current systematic profile, led by quality and momentum.
OGN (Organon & Co.): the counter-case, on value, risk resilience, valuation.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
REGNREGN on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
REGNREGN on combined revenue and EPS growth.
Value
OGNOGN on the peer-relative Value factor, by 27 points.
Momentum
REGNREGN on the Momentum factor, by 22 points.
Lower downside
OGNOGN on Risk Resilience, by 10 points.
Analyst upside
EvenAnalyst targets are level or not covered for both names.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | OGN | REGN | Note |
|---|---|---|---|
| Implied upside to target | +1.8% | +2.7% | Level |
| Target dispersion | 0% | +47% | Lower is tighter analyst agreement |
| Consensus | Hold | Buy | Context, not a primary driver |
| Analysts covering | 1 | 20 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
2 of 6 covered evidence groups favor REGN. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | REGN | 64 vs 68 |
| Fundamentals | REGNon balance | revenue growth 6.7% vs 19%; EPS growth -25.5% vs 80.1%; TTM ROE 23.4% vs 13.8%; gross margin 53% vs 84.9%; operating margin 19.3% vs 25.6% — REGN takes 4 of 5 decided legs, not all of them |
| Valuation | OGN | Value 75 vs 48 |
| Technicals | OGN | Price vs 50-day 0.2% vs 1.9%; vs 200-day 22.2% vs 9.8% |
| Risk Resilience | OGN | Risk Resilience 70 vs 60 |
| Analyst expectations | Even | Target upside 1.8% vs 2.7% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of OGN and REGN and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 4 points. (argues the conclusion is provisional)
- Only 2 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
- The lead has swung materially session to session. (argues the conclusion is provisional)
- The leader's signal state is cleanly positive. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on REGN.
How the comparison changed
120 daily snapshots · Jun 21 – Oct 20REGN lead: Reversed — OGN led by 17 AIQ points 30 sessions ago; REGN now leads by 4.
- Today
- REGN +4
- 64 vs 68
- 7 sessions ago
- REGN +2
- 63 vs 65
- 30 sessions ago
- OGN +17
- 66 vs 49
- 90 sessions ago
- REGN +1
- 67 vs 68
The lead changed hands 2 times in this window, most recently on Oct 15 when REGN moved ahead of OGN.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
4 bullish / 1 bearish / 1 neutral, conflicted
Only OGN
- ATR Contraction - Coiling — neutral, volatility, short horizon (0.33%)
- 52-Week High Proximity — bullish, risk, long horizon (0.2%)
- MACD Bearish Crossover — bearish, momentum, short horizon
4 bullish / 0 bearish
Only REGN
- MACD Bullish Crossover — bullish, momentum, short horizon
Both carry 3 more signals that do not separate them: Golden Cross Active, EMA Ribbon Expansion Bullish, Uptrend Structure Active.
OGN is conflicted, so the timing case there is weaker than the score alone suggests.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.07%, AIQ +1 points).
Price is down while the AIQ Score moved up 4 points over the same session — price and model disagree (price -0.22%, AIQ +4 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1OGN closes the Quality gap — currently 26 points behind, the largest single contributor to REGN's edge.
- 2OGN generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover.
- 3REGN's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
REGN leads on balance| Metric | OGN | REGN |
|---|---|---|
| Revenue growth (YoY) | 6.7% | 19% |
| EPS growth (YoY) | -25.5% | 80.1% |
| Gross margin | 53% | 84.9% |
| Operating margin | 19.3% | 25.6% |
| Return on equity (TTM) | 23.4% | 13.8% |
| Debt to equity | 8.5 | 0.06 |
Performance
Split across windows| Metric | OGN | REGN |
|---|---|---|
| 1 week (5 sessions) | -0.1% | 7.2% |
| 1 month (20 sessions) | 0.4% | 0.4% |
| 3 months (63 sessions) | 1.8% | 24% |
| 6 months (126 sessions) | 55.7% | 8% |
| Year to date | 91.9% | 4.6% |
| 1 year (252 sessions) | 46.7% | 41.9% |
Technicals
OGN has the stronger structure| Metric | OGN | REGN |
|---|---|---|
| RSI (14) | 58.8 | 64.8 |
| ADX (14) | 23.9 | 18.8 |
| Price vs 50-day | 0.2% | 1.9% |
| Price vs 200-day | 22.2% | 9.8% |
| Volatility (1M, annualized) | 3.3% | 31.2% |
Risk
OGN is the more resilient| Metric | OGN | REGN |
|---|---|---|
| Beta | 0.55 | 0.58 |
| Sharpe ratio | 0.85 | 1.05 |
| Sortino ratio | 1.24 | 1.7 |
| Max drawdown | -41.6% | -26.1% |
| Current drawdown | -0.4% | -5.2% |
| Annualized volatility | 66.7% | 33.5% |
| Value at risk (95%) | -4% | -2.7% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, OGN or REGN?
On the Algovestiq AIQ Score, REGN is the stronger of the two as of Oct 21, 2026, scoring 68 against OGN's 64. The edge comes from quality and momentum. OGN is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is OGN or REGN the better buy right now?
REGN carries the stronger systematic profile as of Oct 21, 2026, and the comparison is rated Fragile — 2 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 4 points. Treat the lead as provisional.
Why does the AIQ Score favor REGN over OGN?
The composite weights Quality, Value, Momentum and Risk Resilience. OGN leads Value by 27 points; REGN leads Quality by 26 points; REGN leads Momentum by 22 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, OGN or REGN?
Analyst price targets imply +1.8% upside for OGN and +2.7% for REGN. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, OGN or REGN?
OGN is the better-valued of the two on the peer-relative Value factor. OGN on the peer-relative Value factor, by 27 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, OGN or REGN?
REGN on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, OGN or REGN?
REGN on the Momentum factor, by 22 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, OGN or REGN?
OGN is the more resilient of the two, so the other name carries the higher downside risk. OGN on Risk Resilience, by 10 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is OGN more profitable than REGN?
The profitability evidence is mixed: gross margin 53% vs 84.9%; operating margin 19.3% vs 25.6%; ttm roe 23.4% vs 13.8%. OGN leads on one measure and REGN on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is REGN's lead over OGN getting stronger or weaker?
REGN lead: Reversed — OGN led by 17 AIQ points 30 sessions ago; REGN now leads by 4. This is measured from 120 daily comparison snapshots between 2026-06-21 and 2026-10-20. The lead has changed hands 2 times in that window, most recently on 2026-10-15, when REGN moved ahead of OGN.
What would change the OGN vs REGN verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: OGN closes the Quality gap — currently 26 points behind, the largest single contributor to REGN's edge; OGN generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover; REGN's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about OGN and REGN?
OGN: 4 bullish / 1 bearish / 1 neutral, conflicted. REGN: 4 bullish / 0 bearish. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on OGN is Golden Cross Active (bullish, long horizon). On REGN it is Golden Cross Active (bullish, long horizon).
Compare OGN and REGN with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.